Another patient, who had a related but slightly different form of the disease called a spinal cord diffuse glioma, was rapidly progressing when she joined the trial. By the time she was treated ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

A clinical trial showed CAR-T cell therapy may shrink aggressive brain and spinal cord tumours in young patients.

Glioblastoma is a naturally occurring tumour that belongs to a group of brain tumours called “gliomas” that originate and grow in the brain and spinal cord. Classified as a grade 4 tumour by the World ...

The trial, among the first successes against solid tumours for engineered immune cells known as CAR-T cells - offers hope for ...